🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

CID: Colorado Pediatric Infectious Diseases 3rd yr fellow, Dr. Erin Ho, shows the clinical impact of Strep pneumo PCR testing of pleural fluid in children with complicated pneumonia: 3X⬆️pathogen detection 25%⬇️pts on MRSA tx 5 days faster time to optimal abx #diagnosticstewardship academic.oup.com/cid/advance-ar…

If the urine antibiogram 💧📊 shows cefazolin as a highly active option, why are we so quick 🏃💨 to start empiric ceftriaxone? Fantastic study here! 🤔 Drop your thoughts below! ⏬⏬ #IDtwitter #PedsID @jmarks614 Matt Molloy, MD, MPH Jillian Cotter, MD Mike Tchou

🆕️⚡️⚡️Multicenter, retrospective cohort Jillian Cotter, MD Of 1147 included hospitalized children with CAP , 37% received initial oral antibiotics Children with CAP receiving initial oral Abx had reduced LOS & hospital cost Vs those receiving initial IV Abx …mpublications.onlinelibrary.wiley.com/doi/full/10.10…

IDWeek: Colorado Pediatric Infectious Diseases's clinical micro guru Dr. Samuel Dominguez goes Mano-a-Mano debating the role of cell-free DNA sequencing in #pedsID. Notes that we are an early adopter institution that studies implementation, indications & clinical use scenarios for novel diagnostics like mNGS

👉Hot Take: Just because a patient is hospitalized does not mean their antimicrobial therapy needs to be intravenous. Switch to oral formulations if indicated, I promise you, they will be fine! #IDTwitter #MedTwitter

“We discovered that people who don’t give up have a habit of interpreting setbacks as temporary, local, and changeable.” s.hbr.org/36lgnQU

Women in PHM has selected a new Co-Chair!!!! Congrats to Patricia Tran, MD, MS, FAAP (she/her) !!!! 💥💥💥🥳🥳

Hey look, it’s me! Absolutely honored to have been selected to lead this incredible group of #womeninmedicine (and allies!!)

IV therapy is an entrenched practice, but does it deserve to be crowned as the standard of care? Because when we break it down, the SPC should be the therapy proven to be the safest & most effective option for the patient Whereas IV risks catheter complications,is more burdensome

Despite the historical use of IV antibiotics for the treatment of bone & joint infections, little evidence supports this practice A systematic review* of RCTs comparing oral(PO)to IV therapy for osteomyelitis found no studies in which IV antibiotics were superior to PO therapy

*Oral Is the New IV. Challenging Decades of Blood and Bone Infection Dogma: A Systematic Review Brad Spellberg et Al #idxposts pubmed.ncbi.nlm.nih.gov/34715060/

Do you prescribe cefdinir for common infections? It’s time to rethink your approach! 💊💡 #ChooseWisely #TWDFNR #AntibioticStewardship 🔗: doi.org/10.1002/jhm.13… 🖼️: #VisualAbstract by Alex Chinn, MD, FACP, FHM ✍️: @ JHospMedicine Things We Do For No Reason SIDP Katie Olney Bill Olney Joel Howard

Journal of Hospital Medicine Jillian Cotter, MD Derek Williams @AmbroggioPhD Cristin Fritz Maia Taft, MD Alex Chinn, MD, FACP, FHM Important findings! 📊 Starting kids on oral antibiotics for pneumonia led to shorter hospital stays & lower costs—with no increase in adverse outcomes. Could be a game-changer for antibiotic stewardship & pediatric care! #HospitalMedicine

Thanks Journal of Hospital Medicine for sharing our paper! Is oral the new IV?!@ColoradoPHM Children’s Colorado Research and Innovation Colorado Pediatric Infectious Diseases